HCPCS code J0577 — Inj, brixadi, 7 days or less.
Status: Active.
Effective Apr 1, 2024.
Source: CMS HCPCS Level II.
J0577
ActiveInj, brixadi, 7 days or less
Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Apr 1, 2024
Code type:
alphanumeric
OPPS Status:
G
— Pass-through drugs and biologicals
OPPS APC:
0732
MUE — Medically Unlikely Edits
Maximum units of J0577 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 1 |
| Outpatient Hospital | 1 |
| Practitioner Services | 1 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 58284-0208-01 | Brixadi (weekly dosing) |
| 58284-0216-01 | Brixadi (weekly dosing) |
| 58284-0224-01 | Brixadi (weekly dosing) |
| 58284-0232-01 | Brixadi (weekly dosing) |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2024-Q2Inj, brixadi, 7 days or less